Author

C. L. Martin

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Evolutionary Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:mouse· 2 Assay:proteomics· 2 Approach:statistical model· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:clustering· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

A. Cabello· 1 shared A. Ficht· 1 shared A. Pandey· 1 shared B. J. Luft· 1 shared B. Sulkow· 1 shared C. D. Johnson· 1 shared D. Pante· 1 shared D. Zhang· 1 shared

Activity by Year

2020-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Cabello

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Diverse pathogens activate the host RIDD pathway to subvert BLOS1-directed immune defense

K. M. Wells, K. He, A. Pandey, A. Cabello, D. Zhang, J. Yang, G. Gomez, Y. Liu, H. Chang, X. Li, H. Zhang, L. F. da Costa, R. Metz, C. D. Johnson, C. L. Martin, , P. de Figueiredo

This study shows that pathogens like Brucella and coronavirus MHV exploit the RIDD pathway to degrade BLOS1, impairing lysosomal trafficking and enhancing their intracellular survival.

bioRxiv · Nov 4, 2021Microbiology

Following the Trail of One Million Genomes: Footprints of SARS-CoV-2 Adaptation to Humans

S. Akther, E. Bezrucenkovas, L. Li, B. Sulkow, L. Di, D. Pante, C. L. Martin, B. J. Luft, W. Qiu

This study analyzes one million SARS-CoV-2 genomes to identify human-adaptive mutations and develop a simulator to predict viral evolution under different models.

bioRxiv · May 7, 2021 · PreprintEvolutionary Biology

A non-olfactory shark adenosine receptor activates CFTR with unique pharmacology and structural features

S. Bhanot, G. Hemminger, C. L. Martin, S. G. Aller, J. N. Forrest

The paper clones and characterizes a non-olfactory shark adenosine receptor (A0) that activates CFTR with unique pharmacology and structural features, suggesting evolutionary links to mammalian ADORs.

bioRxiv · Nov 1, 2020Cell Biology